CS logo
small CS logo
The Chaim Sheba Medical Center; Multiple Sclerosis Center

Ramat Gan, Israel
Medical center in Ramat Gan
Derech Sheba 2, Ramat Gan
1,580 Beds

About The Chaim Sheba Medical Center; Multiple Sclerosis Center


Chaim Sheba Medical Center at Tel HaShomer, also Tel HaShomer Hospital, is the largest hospital in Israel, located in the Tel Aviv District city of Ramat Gan at Tel HaShomer neighborhood, Israel. In 2020, Newsweek ranked it as the 9th-best hospital in the world.
There are 1,580 beds in The Chaim Sheba Medical Center; Multiple Sclerosis Center.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at The Chaim Sheba Medical Center; Multiple Sclerosis Center


During the past decade, The Chaim Sheba Medical Center; Multiple Sclerosis Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at The Chaim Sheba Medical Center; Multiple Sclerosis Center


According to Clinical.Site data, the most researched conditions in "The Chaim Sheba Medical Center; Multiple Sclerosis Center" are "Multiple Sclerosis, Primary Progressive" (2 trials), "Influenza" (1 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Chronic Progressive" (1 trials) and "Relapsing Remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "The Chaim Sheba Medical Center; Multiple Sclerosis Center" in a lesser frequency.

Clinical Trials Intervention Types at The Chaim Sheba Medical Center; Multiple Sclerosis Center


Most popular intervention types in "The Chaim Sheba Medical Center; Multiple Sclerosis Center" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (2 trials), "Etrolizumab" (1 trials), "Fenebrutinib" (1 trials), "Oseltamivir" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at The Chaim Sheba Medical Center; Multiple Sclerosis Center


The vast majority of trials in "The Chaim Sheba Medical Center; Multiple Sclerosis Center" are 6 trials for "All" genders.

Clinical Trials Status at The Chaim Sheba Medical Center; Multiple Sclerosis Center


Currently, there are NaN active trials in "The Chaim Sheba Medical Center; Multiple Sclerosis Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in The Chaim Sheba Medical Center; Multiple Sclerosis Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Chaim Sheba Medical Center; Multiple Sclerosis Center, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".